Publications by authors named "M Gaudet"
Long-term disease-free survival and health-related quality of life results of high-dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer treated in a community cancer center.
Brachytherapy
January 2025
Purpose: To determine the long-term disease-free survival, long-term toxicity, and effect on health-related quality of life of a two-fraction regimen of high-dose-rate (HDR) prostate brachytherapy.
Methods And Materials: Patients with low- or intermediate-risk prostate cancer were treated with CT-planned HDR brachytherapy as monotherapy in two implants of 13.5 Gy in one community cancer center.
Purpose: Most breast biopsies are diagnosed as benign breast disease (BBD), with 1.5- to fourfold increased breast cancer (BC) risk. Apart from pathologic diagnoses of atypical hyperplasia, few factors aid in BC risk assessment of these patients.
View Article and Find Full Text PDFArticle Synopsis
- This study looked at whether radiotherapy could help reduce pain from liver cancer in patients who weren't getting better with regular treatments.
- It included 66 patients who were given either radiotherapy and extra care or just extra care alone.
- The researchers wanted to see if the patients felt less pain after a month and found out if the treatment was safe for them.
Background: Multiple chemical sensitivity (MCS) develops in response to repeated small-level chemical exposures or a major exposure in a subset of people, who then experience symptoms that can range from mild to debilitating when exposed to chemicals. The arrival of the COVID-19 pandemic and the stringent health measures put in place may have increased the burden for those living with MCS, as it became more challenging to avoid chemicals that trigger their condition.
Objective: This study aimed to better understand the lived experience of Canadians living with MCS during the first year of the COVID-19 pandemic.